
Equillium, Inc.
EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31
Reports and events: 158 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-12-2016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-18-354533 |
| 2018-11-1516:43 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-029687 |
| 2018-11-1516:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-327998 |
| 2018-11-1306:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-324657 |
| 2018-10-1616:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-18-300246 |
| 2018-10-0206:08 ET | S-1/A | Registration statement, amended | 0001193125-18-290169 |
| 2018-09-2806:08 ET | S-1/A | Registration statement, amended | 0001193125-18-286265 |
| 2018-09-1717:21 ET | S-1 | Registration statement | 0001193125-18-275420 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:43 ET. Listed shows no prices and gives no investment advice.